BioLineRx Ltd.
看多

Mean reversion for BLRX

192
BLRX dumped over 40% yesterday on dilution news, an overreaction from the market imo. Bought the bottom around $0.15 which is way undervalued for what the company has in the pipeline. Company is now cash healthy for a while with $10 million for research. It's trading at $1,49 on the TASE - so heavy arbitrage opportunity for market makers here. Next to that, it has a buy rating and target for $9.00/share - that was pre-dilution, so you know what, let's cut that in half to $4.50 - works for me too.

Buying the blood and targeting a 100 to 500% move for mean reversion.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。